DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
A skin-interfaced wireless wearable device and data analytics approach for sleep-stage and disorder detection
This work introduces an approach to continuous sleep monitoring using low-power multimodal mechanoacoustic (LMA) sensors. Unlike traditional sleep diagnostics and existing wearable technologies, LMA directly measures respiratory biomarkers. The systematic signal processing pipeline extracts features of activities, respiratory and heart rate variability, essential for detecting sleep stages and disorders. Paired with an interpretable machine learning (ML) model, LMA-SleepNet, this approach delivers accurate, generalized, and personalized sleep analysis. Its superior performance in distinguishing sleep stages and apnea events highlights the translational potential of this technology for continuous sleep monitoring in both clinical and home settings, offering broad applicability across diverse populations.
Collaborative UCF Research Team Develops Technique for Rapid Isolation and Characterization of Exosomes
Researchers from the College of Sciences and College of Medicine have developed a quick, easy and cost-effective method to isolate and study exosomes, which can help diagnose diseases such as cancer and Alzheimer’s earlier. Exosomes are nano-sized vesicles released by cells that can carry information which contain proteins, DNA and other molecules from the cells that created them. They serve as messengers giving a view of what’s happening inside the body, which makes them promising tools for early, noninvasive disease detection.
Innovations driving efficient adherent cell cultivation in biotech
Scaling adherent cell culture from early-stage research to commercial manufacturing remains a significant challenge for biotechs, with complexities in process changes, validation, and automation. Joel Eichmann, co-founder and managing director of Green Elephant Biotech, explains how the company’s innovative CellScrew technology enables a seamless scale-up, reducing risk and cost while maintaining consistent cell culture conditions.
In this Q&A, he discusses key hurdles in scaling adherent cell processes and how Green Elephant’s approach supports biotechs at every development stage.
German beauty startup is looking for a contract manufacturer for high-quality, vegan lip products under a commercial agreement
The German startup is specialised in the development and sales of high-quality, vegan lip products designed for a style-conscious, diverse Gen Z community. They are looking for a manufacturing partner, specialised in lipstick and lip balm production, for a private label production. A long-term collaboration under a commercial agreement is desired.
Innovative home monitoring service aims to improve care for patients with dementia
Imperial College Healthcare NHS Trust has launched a new NHS service for people living with dementia, offering remote, at-home monitoring that provides specialist support. It is hoped the service can lead to more appropriate interventions and earlier treatments for some of the most vulnerable people living in the community.
MinderCare uses a network of sensors installed in the home to send data back to a dedicated team of doctors, nurses and other clinical specialists. This team use the information to better understand how the person is managing their daily routine, provide tailored advice and identify early signs of changing health and care needs which may help reduce unnecessary hospital admissions.
This new service provides access to a cutting-edge technology system, informed by over 10 years of NHS research and underpinned by clinical care and support, including infrastructure support from the NIHR Imperial Biomedical Research Centre. The MinderCare service model has been developed by researchers at the UK Dementia Research Institute (UK DRI) Care Research & Technology Centre at Imperial College London and is led by Professor David Sharp, in partnership with clinical teams at Imperial College Healthcare NHS Trust and Surrey and Borders Partnership NHS Foundation Trust. MinderCare has been funded and supported by the not-for-profit medical research charity, LifeArc who are dedicated to bringing the benefits of research closer to direct patient care.
MinderCare aims to enhance the quality of life for people living with dementia and their families, by offering medical teams access to data that could help maintain independence for longer for many by identifying areas they may need more support with. This can also provide much-needed reassurance for families and friends.
Sawai Pharmaceutical adds three new technologies to its formulation technology brand — improving print durability, evaluating the taste of OD tablets, and visualizing taste using AI.
Sawai Pharmaceutical has added three new technologies to its formulation technology brand, “SAWAI HARMOTECH®.” These include “INJIKEEP®,” which enhances the durability of printed text; “ODITEX®,” which quantitatively evaluates the texture and mouthfeel of OD tablets using equipment; and “TASTEYE®,” which visualizes the taste of medications using AI. All three are proprietary technologies that have either been patented or are currently pending patent applications.“ODITEX®” uses a tensile press and rheometer to scientifically evaluate the mouthfeel during disintegration, which was previously assessed through sensory testing or empirical rules. “TASTEYE®” combines taste sensors and AI to quantify the differences in taste between active ingredients and changes in taste due to drug interactions.While evaluations of physical properties such as tablet hardness have been conducted in the past, this is the first attempt to combine such evaluations with sensory assessments of ease of swallowing and quantify the results. Going forward, the company plans to use these technologies to map the physical properties of developed formulations to indicators of ease of swallowing and further visualize taste changes quantitatively, thereby providing patients with objective information about the ease of swallowing of medications.
Ultrasound Unlocks a Safer, Greener Way To Make Hydrogels
Conventional hydrogel manufacturing relied on chemical initiators, some of which were harmful. Sound waves generate microscopic bubbles, which collapse with enormous energy and trigger gel formation within minutes. This method also enables the formation of hydrogels inside the body for the treatment of injuries and tissue damage without surgery.
Study uncovers a specialized gut-brain pathway for glucose sensing
On July 9, KAIST (President Kwang Hyung Lee) announced that the research was led by Professor Greg S.B. Suh of the Department of Biological Sciences in collaboration with Professor Young-Gyun Park (BarNeuro), Professor Seung-Hee Lee (Department of Biological Sciences), and researchers at Albert Einstein College of Medicine in New York.
The team demonstrated that, in a state of hunger, animals are capable of detecting and preferentially selecting D-glucose in the gut via a specialized gut-brain circuit.
While it has long been known that the gut transmits caloric information to the brain to regulate appetite—primarily through suppressing hunger-related neurons in the hypothalamus—this study is the first to reveal a nutrient-specific neural pathway that allows the brain to detect glucose itself, not just general caloric content.
Introducing KneeMo®: The First Smart Wearable Designed to Relieve Knee Pain During Activity and Improve Muscle Function
Developed by Dr. Tom Andriacchi, Professor Emeritus at Stanford University, and Dr. Jenny Hledik, a biomechanical engineer specializing in human movement, KneeMo is built on over five decades of research in joint mechanics and rehabilitation. Chronic knee pain affects 25% of adults worldwide, often stemming from osteoarthritis, injury, or age-related decline. Without effective intervention, pain and muscle weakness can worsen over time, limiting mobility and independence.
The launch comes at a pivotal time, as more people are living longer and striving to maintain an active lifestyle well into later life. KneeMo fills a critical, unmet need for a drug-free, wearable solution that supports mobility by reducing pain and enhancing muscle function during movement. By helping people stay active, it addresses the decline in health and quality of life that often results when pain makes movement difficult or unsustainable.
KneeMo uses smart, motion-sensing technology that combines engineering, neurophysiology, and decades of gait laboratory research to reduce knee pain and enhance quadriceps muscle function during walking, stair climbing, jogging, and other daily activities. Using patented technology, the device senses each user’s unique motion patterns and applies motion-activated intermittent vibration to block pain signals and recruit muscles at a critical phase of gait.
FDA Grants Breakthrough Device Designation to TOBY’s AI-Powered Urine Test for Early Bladder Cancer Detection
TOBY, Inc. has developed the TOBY Test, a non-invasive bladder cancer detection method that analyzes volatile organic compounds (VOCs) in urine using artificial intelligence (AI), and has received Breakthrough Device Designation from the US Food and Drug Administration (FDA). This designation will enable TOBY to collaborate more frequently with the FDA to accelerate clinical development and achieve early and accessible cancer screening.Bladder cancer is the sixth most common cancer in the United States, but it has a high recurrence rate and relies on invasive tests such as cystoscopy. TOBY's test is painless, low-cost, and uses gas chromatography-mass spectrometry to analyze VOCs, combined with proprietary AI technology to generate real-time cancer risk scores.TOBY is also preparing for clinical trials for multiple cancers and aims to realize large-scale screening based on VOC biomarkers and AI.
Journey Pregnancy App Integrates FaceHeart’s FDA-Cleared Mobile Vitals Scanner
Emagine Solutions Technology has partnered with FaceHeart to integrate contactless vital signs scanning technology into The Journey Pregnancy app, enabling pregnant women to measure blood pressure and other maternal health indicators using their smartphone cameras without additional equipment.
The company’s app now includes FaceHeart Vitals technology through a feature called “Vital View,” allowing users to capture six critical maternal health vital signs through a 50-second selfie video. The measurements include heart rate, blood pressure, respiration rate, oxygen saturation, heart rate variability, and stress index.
FaceHeart’s technology has received two FDA 510(k) clearances as Class II Software as a Medical Device, covering pulse rate measurement and respiratory rate measurement. The AI-driven algorithms process facial images in real-time before discarding them, with edge computing ensuring data privacy compliance with HIPAA standards.
MIT engineers develop electrochemical sensors for cheap, disposable diagnostics
Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such as influenza and HIV.
These electrochemical sensors make use of a DNA-chopping enzyme found in the CRISPR gene-editing system. When a target such as a cancerous gene is detected by the enzyme, it begins shearing DNA from the electrode nonspecifically, like a lawnmower cutting grass, altering the electrical signal produced.
One of the main limitations of this type of sensing technology is that the DNA that coats the electrode breaks down quickly, so the sensors can’t be stored for very long and their storage conditions must be tightly controlled, limiting where they can be used. In a new study, MIT researchers stabilized the DNA with a polymer coating, allowing the sensors to be stored for up to two months, even at high temperatures. After storage, the sensors were able to detect a prostate cancer gene that is often used to diagnose the disease.
A pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring has obtained Medicare approval for its oral appliance.
Vivos Therapeutics, Inc. (NASDAQ: VVOS), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, (hereinafter referred to as “Vivos” or “the Company”) announced today that the VidaSleep™ oral device, featuring Vivos' patented and FDA-approved Unilateral Bite Block technology, has been approved by Medicare and Medicaid Services Center (CMS) for use as a treatment for mild to moderate OSA and snoring in adults, following review by a Medicare and Medicaid Services Center (CMS) price setting, data analysis, and coding (PDAC) contractor.